Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Auteurs : Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, Von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J, + collaborators (among others :, Nogaret JM
Année : 2016
Journal : Lancet
Volume : 387
Pages : 866-73